HUMNYSEHospital & Medical Service PlansFiscal year ends December 31

HUMANA INC

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 29, 2026

$414.98+1.82 (+0.44%)

Close on Oct 19, 2026

Market cap: $50.07B
P/E (TTM): 44.2
Dividend yield: 0.85%

HUMANA INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31
Revenue	129,664	117,761	106,374	92,870	83,064	77,155	64,888	56,912	53,767	54,379	54,289	48,500	41,313	39,126	36,832	33,596	30,743	28,946	25,290
Selling, General & Admin	15,450	13,696	13,188	12,671	10,121	10,052	7,381	7,525	6,567	7,173	7,295	7,639	6,355	5,830	5,395	4,380	4,014	3,945	3,476
Total Costs & Expenses	126,960	115,199	102,361	89,070	79,916	72,169	61,696	53,812	49,505	52,638	51,942	46,138	39,252	37,110	34,488	31,742	29,035	27,873	23,932
Operating Income	2,704	2,562	4,013	3,800	3,148	4,986	3,192	3,100	4,262	1,741	2,347	2,362	2,061	2,016	2,344	1,854	1,708	1,073	1,358
Interest Expense	631	660	493	401	326	283	242	218	242	189	186	192	140	105	109	105	106	80	69
Interest & Investment Income	1,006	1,226	1,069	382	187	1,154	501	514	405	389	474	377	375	391	366	329	296	220	314
Income from Equity Investments	-102	-94	-63	-4.00	65	74	14	11	0	0	–	–	–	–	–	–	–	–	–
Other Non-Operating Income	-451	-181	-137	-68	532	-103	506	-33	0	0	–	–	–	–	–	–	–	–	–
Merger & Restructuring Charges	–	–	–	–	–	–	47	–	148	–	–	–	–	–	–	–	–	–	–
Asset Impairment Charges	253	200	91	0	0	0	0	0	0	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Investments	–	0	1.00	-123	-341	746	–	–	–	–	–	–	–	–	–	5.65	19	-79	12
Gain (Loss) on Sale of Assets	-67	0	0	237	0	0	0	-786	0	0	270	0	0	–	–	-0.03	0.23	-0.01	14
Pretax Income	1,438	1,620	3,325	3,568	3,419	4,674	3,470	2,074	4,020	1,552	2,431	2,170	1,921	1,911	2,235	1,749	1,602	993	1,289
Income Tax Expense	250	413	836	762	485	1,307	763	391	1,572	938	1,155	1,023	690	689	816	650	562	346	456
Net Income incl. Noncontrolling Interests	1,203	1,214	2,484	2,802	2,934	3,367	2,707	–	–	–	–	–	–	–	–	–	–	–	–
Minority Interest in Earnings	15	7.00	-5.00	-4.00	1.00	0	0	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	1,188	1,207	2,489	2,806	2,933	3,367	2,707	1,683	2,448	614	1,276	1,147	1,231	1,222	1,419	1,099	1,040	647	834
EPS (Basic)(per share)	9.87	10.01	20.09	22.20	22.79	25.47	20.20	12.24	16.94	4.11	8.54	7.44	7.81	7.56	8.58	6.55	6.21	3.87	5.00
EPS (Diluted)(per share)	9.84	9.98	20.00	22.08	22.67	25.31	20.10	12.16	16.81	4.07	8.44	7.36	7.73	7.47	8.46	6.47	6.15	3.83	4.91
Shares Outstanding (Basic, Weighted)(shares)	120	121	124	126	129	132	134	137	144	149	149	154	158	161	165	168	167	167	–
Shares Outstanding (Diluted, Weighted)(shares)	121	121	124	127	129	133	135	138	146	151	151	156	159	163	168	170	169	169	–
Dividend per Share(per share)	3.54	3.54	3.44	3.06	2.73	2.43	2.15	1.90	1.49	1.16	1.14	1.10	1.06	1.02	0.75	0.00	–	–	–
EBITDA	3,402	3,401	4,792	4,509	3,744	–	–	3,544	4,672	2,129	2,701	2,690	2,370	2,354	2,647	2,117	1,958	1,293	1,543
Premiums Earned	122,825	112,104	101,272	87,712	79,822	74,186	62,948	54,941	52,380	53,021	52,409	45,959	38,829	37,009	35,106	32,712	29,927	28,065	24,434
Net Investment Income	1,006	1,226	1,069	382	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Policyholder Benefits & Claims	110,812	100,664	88,394	75,690	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin: –
Operating margin: 1.8%
Net margin: 0.8%
Return on equity, FY2025: 7.0%

Financial strength

Current ratio: 1.77
Debt to equity: 0.75
Debt to assets: 25.3%
Cash to current liabilities: 23.0%

Valuation

P/E ratio: 44.2
Price to sales: 0.36
Price to book: 2.69
Dividend yield: 0.85%